{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T04:21:47Z","timestamp":1787458907025,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.tice.2026.103847","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:21:54Z","timestamp":1786033314000},"page":"103847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Protective effects of dapagliflozin against methotrexate-induced liver injury: Involvement of Nrf2\/HO-1 and NLRP3 inflammasome"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6980-4726","authenticated-orcid":false,"given":"Gellan Alaa Mohamed","family":"Kamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamoudi Aliwi","family":"Mousah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem Abdalsatar","family":"Abdalrazaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103847_bib1","article-title":"The dynamic interplay between AMPK\/NF\u03baB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury","volume":"147","author":"Abd El-Fattah","year":"2022","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.tice.2026.103847_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111298","article-title":"The enteroprotective effect of nifuroxazide against methotrexate-induced intestinal injury involves co-activation of PPAR-$\u03b3$, SIRT1, Nrf2, and suppression of NF-$\u03ba$B and JAK1\/STAT3 signals","volume":"127","author":"Abd-Alhameed","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.tice.2026.103847_bib3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11033-024-09792-z","article-title":"Melatonin mitigated methotrexate-induced hepatotoxicity through interrelated biological processes","volume":"51","author":"Abdallah","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tice.2026.103847_bib4","first-page":"1","article-title":"Amino acids protect against methotrexate-induced hepatorenal toxicity in vitro and in vivo","author":"Abdelaziz","year":"2026","journal-title":"Naunyn-Schmiede\u2019s Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.tice.2026.103847_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5114\/ceh.2023.132251","article-title":"Methotrexate-induced hepatotoxicity in rats and the therapeutic properties of vitamin E: a histopathologic and flowcytometric research","volume":"9","author":"Akman","year":"2023","journal-title":"Clin. Exp. Hepatol."},{"issue":"12","key":"10.1016\/j.tice.2026.103847_bib6","article-title":"Repurposing Dapagliflozin for Mitigation of the Kidney Injury Triggered by Cadmium in Rats: Role of Autophagy, Apoptosis, and the SIRT1\/Nrf2\/HO-1 Pathway","volume":"17","author":"Arab","year":"2024","journal-title":"Pharm. (Basel Switz.)"},{"key":"10.1016\/j.tice.2026.103847_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109368","article-title":"Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK\/mTOR, HMGB1\/RAGE and Nrf2\/HO-1 pathways","volume":"335","author":"Arab","year":"2021","journal-title":"Chem. - Biol. Interact."},{"key":"10.1016\/j.tice.2026.103847_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111566","article-title":"Involvement of Nrf2-PPAR-$\u03b3$ signaling in Coenzyme Q10 protecting effect against methotrexate-induced testicular oxidative damage","volume":"129","author":"Arafa","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.tice.2026.103847_bib9","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.3390\/ijms24097789","article-title":"An overview of the cardioprotective effects of novel antidiabetic classes: focus on inflammation, oxidative stress, and fibrosis","volume":"24","author":"Balogh","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103847_bib10","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"issue":"6","key":"10.1016\/j.tice.2026.103847_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70373","article-title":"Protective effects of chrysin against diclofenac-induced nephrotoxicity in rats via attenuation of oxidative stress, apoptosis and endoplasmic reticulum stress","volume":"39","author":"Caglayan","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"11","key":"10.1016\/j.tice.2026.103847_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13112633","article-title":"Comparative hepatoprotective effects of dapagliflozin and trimetazidine in diabetic rats with doxorubicin-induced liver injury","volume":"13","author":"Ciftel","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.tice.2026.103847_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/omcl\/4538420","article-title":"Nrf2 activation in inflammatory diseases: a review of natural and synthetic modulators","author":"Costa","year":"2026","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"11\u201312","key":"10.1016\/j.tice.2026.103847_bib14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/17425255.2025.2585435","article-title":"Phytoconstituents as therapeutic agents in combating methotrexate-induced hepatotoxicity and nephrotoxicity","volume":"21","author":"Dogra","year":"2025","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"issue":"10\u201312","key":"10.1016\/j.tice.2026.103847_bib15","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1089\/ars.2020.8257","article-title":"Loop between NLRP3 inflammasome and reactive oxygen species","volume":"36","author":"Dominic","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tice.2026.103847_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2025.127784","article-title":"Molybdenum induced hepatic impairments via dysregulating NLRP3, JAK1\/STAT3 and NF-$\u03ba$B pathway: A dose dependent toxicity assessment","author":"El Safadi","year":"2025","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"4","key":"10.1016\/j.tice.2026.103847_bib17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10787-021-00818-7","article-title":"Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NF$\u03ba$B\/AMPK\/NLRP3 axis","volume":"29","author":"El-Rous","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.tice.2026.103847_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119296","article-title":"Mangiferin mitigates methotrexate-induced liver injury and suppresses hepatic stellate cells activation in rats: Imperative role of Nrf2\/NF-$\u03ba$B\/NLRP3 signaling axis","volume":"340","author":"El-Sayed","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.tice.2026.103847_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40360-025-00898-z","article-title":"Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis","volume":"26","author":"Fan","year":"2025","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.tice.2026.103847_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116991","article-title":"Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1\/AMPK\/PGC1$\u03b1$\/FoxO1 axis","volume":"489","author":"Hassan","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.tice.2026.103847_bib21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/08923973.2025.2496661","article-title":"Dapagliflozin alleviates thioacetamide induced-liver fibrosis in rats via controlling the Nrf2\/HO-1 and TLR4\/TGF-$\u03b2$1\/PI3K signaling pathways","volume":"47","author":"Hassan","year":"2025","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.tice.2026.103847_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108503","article-title":"Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation","volume":"104","author":"Hazem","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tice.2026.103847_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109791","article-title":"Dapagliflozin for nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"185","author":"He","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"5","key":"10.1016\/j.tice.2026.103847_bib24","article-title":"NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers","volume":"11","author":"Hurtado-Navarro","year":"2022","journal-title":"Antioxid. (Basel Switz.)"},{"issue":"4","key":"10.1016\/j.tice.2026.103847_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/08923973.2025.2519597","article-title":"Effect of dapagliflozin on sepsis-induced kidney injury in a rat model: modulation of the NLRP3 pathway","volume":"47","author":"Ilhan","year":"2025","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"5","key":"10.1016\/j.tice.2026.103847_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70300","article-title":"Vinpocetine mitigates methotrexate-induced liver injury in rats through modulating intercellular communication","volume":"39","author":"Kamel","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.tice.2026.103847_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ph17040431","article-title":"Silibinin\u2019s effects against methotrexate-induced hepatotoxicity in adjuvant-induced arthritis rat model","volume":"17","author":"Khawaja","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.tice.2026.103847_bib28","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s11033-023-08286-8","article-title":"Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2\/HO-1 and Bax\/Bcl2\/Caspase-3 signaling pathways","volume":"50","author":"K\u0131z\u0131l","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"18","key":"10.1016\/j.tice.2026.103847_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.21037\/atm.2019.09.03","article-title":"The SGLT2 inhibitor dapagliflozin attenuates the activity of ROS-NLRP3 inflammasome axis in steatohepatitis with diabetes mellitus","volume":"7","author":"Leng","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.tice.2026.103847_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178185","article-title":"Lactobacillus reuteri attenuates methotrexate-induced liver injury via modulation of oxidative stress and inflammation through HO-1\/GPX4 and NF-$\u03ba$B\/NLRP3 pathways","volume":"1006","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tice.2026.103847_bib31","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.2147\/JIR.S532908","article-title":"NLRP3 inflammasome activation in liver disorders: from molecular pathways to therapeutic strategies","author":"Ma","year":"2025","journal-title":"J. Inflamm. Res."},{"issue":"21","key":"10.1016\/j.tice.2026.103847_bib32","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"New. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.tice.2026.103847_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27052110","article-title":"Cellular anti-apoptotic effects of dapagliflozin in methotrexate-induced liver toxicity: Bax\/Bcl-2\/Cyt-C\/Cas-9\/Cas-3 signaling pathway","volume":"27","author":"Sarman","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.tice.2026.103847_bib34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/biology13090672","article-title":"Dapagliflozin: a promising strategy to combat cisplatin-induced hepatotoxicity in Wistar rats","volume":"13","author":"Satyam","year":"2024","journal-title":"Biology"},{"issue":"23","key":"10.1016\/j.tice.2026.103847_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315116","article-title":"Methotrexate-induced liver injury is associated with oxidative stress, impaired mitochondrial respiration, and endoplasmic reticulum stress in vitro","volume":"23","author":"Schmidt","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103847_bib36","unstructured":"U.S. Food and Drug Administration. (n.d.) FDA. Farxiga (dapagliflozin) Prescribing Information."},{"issue":"1","key":"10.1016\/j.tice.2026.103847_bib37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11033-022-07928-7","article-title":"Chrysin mitigates diclofenac-induced hepatotoxicity by modulating oxidative stress, apoptosis, autophagy and endoplasmic reticulum stress in rats","volume":"50","author":"Var\u0131\u015fl\u0131","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.tice.2026.103847_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12072-024-10758-3","article-title":"Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"19","author":"Weng","year":"2025","journal-title":"Hepatol. Int."},{"issue":"4","key":"10.1016\/j.tice.2026.103847_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"New. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.tice.2026.103847_bib40","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/ijms24043067","article-title":"The role of the NLRP3 inflammasome and programmed cell death in acute liver injury","volume":"24","author":"Yu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tice.2026.103847_bib41","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2025.2495111","article-title":"Dapagliflozin ameliorates kidney injury following limb ischemia-reperfusion via the AMPK\/SIRT1\/NLRP3 pathway","volume":"47","author":"Zhu","year":"2025","journal-title":"Ren. Fail."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626005410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626005410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T03:54:17Z","timestamp":1787457257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626005410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":41,"alternative-id":["S0040816626005410"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103847","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of dapagliflozin against methotrexate-induced liver injury: Involvement of Nrf2\/HO-1 and NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103847"}}